Project Summary
Palliative care is an interdisciplinary model of care with the overarching goal of improving quality of life for
patients with serious illness through symptom management, provision of psychosocial support, elicitation of
preferences and aiding decision-making. The American Society of Clinical Oncology guidelines recommend
early integration of specialist palliative care for patients with advanced cancer, and use of specialist palliative
care has been associated with improved end-of-life quality metrics for patients with cancer on a population-
level. Thus, the importance of specialist palliative care as a key component of high-quality cancer care has
been established. Despite its demonstrated effectiveness and inclusion in national guidelines, disparities in
receipt of specialist palliative care may exist. In patients with cancer, studies have demonstrated disparities in
other guideline-concordant treatments, as well as in end-of-life care. Because of the difficulty in identifying
receipt of specialist palliative care in population-level data, prior studies examining disparities have only used
single-center data, examined flawed proxies for palliative care such as delivery of non-curative treatment, or
palliative care not specifically delivered by specialists. In our R37 MERIT award, we created a novel national
database comprised of Medicare claims, data on palliative care program characteristics from the National
Palliative Care Registry, and prospectively collected data on palliative care clinicians that allow for accurate
ascertainment of specialist palliative care use. These data provide an unprecedented opportunity to investigate
disparities in access to specialist palliative care, related outcomes, and potential drivers of disparities. The
proposed research will target important knowledge gaps by providing 1) a determination of the extent that
disparities in specialist palliative care use exist in a large, multicenter, national cohort across a broad
population of patients with metastatic cancer, 2) a quantification of the consequences of disparities with
respect to end-of-life quality metrics, and 3) an investigation of potential causes of disparities that may guide
future directions of research aimed at ameliorating disparities. This project represents a critical scientific
advance in understanding how to ensure the equitable delivery of high-quality care for all patients with cancer.
Error Notice
The database may currently be offline for maintenance and should be operational soon. If not, we have been notified of this error and will be reviewing it shortly.
We apologize for the inconvenience.
- The DCCPS Team.